These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
457 related items for PubMed ID: 11755929
1. Cytokine-activated Jak-2 is involved in inducible nitric oxide synthase expression independent from NF-kappaB activation in vascular smooth muscle cells. Doi M, Shichiri M, Katsuyama K, Ishimaru S, Hirata Y. Atherosclerosis; 2002 Jan; 160(1):123-32. PubMed ID: 11755929 [Abstract] [Full Text] [Related]
2. Cytokine-activated p42/p44 MAP kinase is involved in inducible nitric oxide synthase gene expression independent from NF-kappaB activation in vascular smooth muscle cells. Doi M, Shichiri M, Katsuyama K, Marumo F, Hirata Y. Hypertens Res; 2000 Nov; 23(6):659-67. PubMed ID: 11131279 [Abstract] [Full Text] [Related]
3. Role of nuclear factor-kappaB activation in cytokine- and sphingomyelinase-stimulated inducible nitric oxide synthase gene expression in vascular smooth muscle cells. Katsuyama K, Shichiri M, Marumo F, Hirata Y. Endocrinology; 1998 Nov; 139(11):4506-12. PubMed ID: 9794459 [Abstract] [Full Text] [Related]
4. Differential inhibitory actions by glucocorticoid and aspirin on cytokine-induced nitric oxide production in vascular smooth muscle cells. Katsuyama K, Shichiri M, Kato H, Imai T, Marumo F, Hirata Y. Endocrinology; 1999 May; 140(5):2183-90. PubMed ID: 10218970 [Abstract] [Full Text] [Related]
5. A pyrrolidinone derivative inhibits cytokine-induced iNOS expression and NF-kappaB activation by preventing phosphorylation and degradation of IkappaB-alpha. Katsuyama K, Hirata Y. J Biochem; 2001 Apr; 129(4):585-91. PubMed ID: 11275558 [Abstract] [Full Text] [Related]
6. Cytokine induction of NO synthase II in human DLD-1 cells: roles of the JAK-STAT, AP-1 and NF-kappaB-signaling pathways. Kleinert H, Wallerath T, Fritz G, Ihrig-Biedert I, Rodriguez-Pascual F, Geller DA, Förstermann U. Br J Pharmacol; 1998 Sep; 125(1):193-201. PubMed ID: 9776360 [Abstract] [Full Text] [Related]
8. Cytokine-stimulated inducible nitric oxide synthase expression in astroglia: role of Erk mitogen-activated protein kinase and NF-kappaB. Marcus JS, Karackattu SL, Fleegal MA, Sumners C. Glia; 2003 Jan 15; 41(2):152-60. PubMed ID: 12509805 [Abstract] [Full Text] [Related]
11. Effects of barbiturates on the expression of the inducible nitric oxide synthase in vascular smooth muscle. Kessler P, Kronemann N, Hecker M, Busse R, Schini-Kerth VB. J Cardiovasc Pharmacol; 1997 Dec 15; 30(6):802-10. PubMed ID: 9436821 [Abstract] [Full Text] [Related]
13. beta-very low density lipoprotein enhances inducible nitric oxide synthase expression in cytokine-stimulated vascular smooth muscle cells. Takahashi M, Takahashi S, Shimpo M, Naito A, Ogata Y, Kobayashi E, Ikeda U, Shimada K. Atherosclerosis; 2002 Jun 15; 162(2):307-13. PubMed ID: 11996950 [Abstract] [Full Text] [Related]
18. Non-NF-kappaB elements are required for full induction of the rat type II nitric oxide synthase in vascular smooth muscle cells. Zhang H, Teng X, Snead C, Catravas JD. Br J Pharmacol; 2000 May 15; 130(2):270-8. PubMed ID: 10807663 [Abstract] [Full Text] [Related]
19. 4-hydroxynonenal prevents NO production in vascular smooth muscle cells by inhibiting nuclear factor-kappaB-dependent transcriptional activation of inducible NO synthase. Hattori Y, Hattori S, Kasai K. Arterioscler Thromb Vasc Biol; 2001 Jul 15; 21(7):1179-83. PubMed ID: 11451748 [Abstract] [Full Text] [Related]